May 05, 2025

Ustekinumab Biosimilar Receives Interchangeability Approval

Selarsdi (ustekinumab-aekn) was approved by the FDA as an interchangeable biosimilar to Stelara (ustekinumab) for all approved indications, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Conexiant

May 05, 2025

Missed Screenings? Anal Cancer Surge in Women

Rates rising 4.3% in white women over 65, outpacing increases in other demographics.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

Health Care Shortage: Who’s Left Out?

“The ER then says, ‘OK, you should follow up with your primary care provider,’ and they’re like, ‘We don’t have one.’”

KFF Health News

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant

April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 29, 2025

RadSearch Transforms Radiology Report Retrieval 

RadSearch could enhance radiologists' ability to find precedent cases.

Conexiant

April 28, 2025

Early Infant Antacid Use Linked to Celiac

Cohort results may reflect confounding by health care utilization behavior, researchers wrote, as two observational designs yielded divergent associations.

Conexiant